Palliative Care in Advanced Parkinson’s Disease: Descriptive Analysis and Symptom Impact
Objective: These preliminary study aims to describe the primary clinical features of Parkinson's disease patients requiring palliative care, as assessed by the Edmonton Symptom Assessment…Development and Validation of a Clinical Scale for Distinguishing Multiple System Atrophy from 4-Repeat Tauopathies
Objective: We aimed to develop a clinical scale that distinguishes between Multiple System Atrophy (MSA) and 4-repeat tauopathies (4RT: CBD, PSP) using a standardized neurological…Sex Cerebral Vasoreactivity Differences in Parkinson’s Disease: Uncovering the Tip of the Iceberg
Objective: To determine sex differences in cerebral vasoreactivity (cVR) in patients with Parkinson’s disease (PD) and its association with the clinical spectrum of the disease.…Attention/Working memory and Executive Tests in Parkinson’s disease: Review, Critique and Recommendations
Objective: To evaluate the clinimetric properties of the Attention/Working memory and Executive domain tests used in Parkinson’s disease (PD) on behalf of the Movement Disorder…Video-based Machine Rating Model for MDS-UPDRS III in Parkinson’s disease: A Proof-of-concept Pilot Study
Objective: To develop a video-based machine rating system for the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) III. Background: MDS-UPDRS III…Neuropsychological Tests of Language, Memory, and Visuospatial Function in Parkinson’s Disease: Review, Critique and Recommendations
Objective: To evaluate the psychometric properties of Language, Memory, and Visuospatial Function tests in Parkinson’s Disease (PD) on behalf of the Movement Disorder Society (MDS)…Artificial Intelligence and Visual Analysis of Movements in Parkinson’s Disease
Objective: To evaluate the use of artificial intelligence in the analysis and classification of movements in Parkinson's disease. Background: Artificial intelligence (AI) is a powerful…MDS-UPDRS III Off Severity Level changes as a marker of DBS response
Objective: To determine the change in MDS-UPDRS III severity level after Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) in patients with Parkinson’s disease (PD) and evaluate…Reliability of the severity subscale of the Toronto Western Spasmodic Torticollis Rating Scale in a multidisciplinary team
Objective: To assess the inter-rater reliability of the severity subscale of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in a multidisciplinary team. Background: The…Living with Parkinson’s disease scale: First validation study among English-speaking population
Objective: To analyse the psychometric properties of the English version of the Living with long term conditions (LwLTCs) scale in people living with Parkinson’s disease…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 32
- Next Page »